Calendar Dova Pharmaceuticals, Inc.

Equities

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-0.07%	+269.92%

2019	Dova Pharmaceuticals Presents Additional Analyses from the Phase 3 Study - Core and Extension Phase - with Avatrombopag	CI
2019	Dova Pharmaceuticals Presents Additional Analyses from the Phase 3 Study Core and Extension Phase	CI

3eb96.hGtsrX7_40ts6t80-5d6mv-CD9sfMGVJq1fotCSJa0k.xQ1b-BjImiYVgIZQiPVDzanQS5JpBCo_-G-Q-Uq9DQ7mWhyVMbW8KRSQmg~9ca0d27431a58adb07858c257ac20c56

No events available

2019-11-12 11:45 am	Credit Suisse Healthcare Conference
2019-10-02 04:10 pm	Cantor Global Health Care Conference
2019-09-24 02:30 pm	Ladenburg Thalmann Health Care Conference
2019-09-23	Investor Meeting
2019-09-09 12:30 pm	H.C. Wainwright Global Investor Conference
2019-08-13 02:30 pm	Wedbush PacGrow Healthcare Conference
2019-08-06 09:00 am	Interim 2019 Earnings Call
2019-08-06 07:00 am	Interim 2019 Earnings Release
2019-07-07 04:30 am	International Society on Thrombosis and Haemostasis Scientific Meeting - Abstract PB0399
2019-07-07 04:30 am	International Society on Thrombosis and Haemostasis Scientific Meeting - Abstract PB0418
2019-07-07 04:30 am	International Society on Thrombosis and Haemostasis Scientific Meeting - Abstract PB0417
2019-07-07 04:30 am	International Society on Thrombosis and Haemostasis Scientific Meeting - Abstract PB0416
2019-06-27 09:00 am	DOPTELET FDA Approval Call
2019-06-04 11:00 am	Jefferies Healthcare Conference
2019-05-20 02:00 pm	UBS Global Healthcare Conference
2019-05-07 09:00 am	Q1 2019 Earnings Call
2019-05-06	Q1 2019 Earnings Release
2019-04-25	Annual General Meeting
2019-04-09 04:30 am	H. C. Wainwright Global Life Sciences Conference
2019-03-05 09:00 am	FY 2018 Earnings Call

Fiscal Period	December	2017	2018
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	10,4 10,3 0.4%
EBITDA Million USD	Released Forecast Spread	-29,2 -29,0 -0.72%	-71,0 -73,4 3.25%
EBIT Million USD	Released Forecast Spread	-29,2 -29,0 -0.72%	-71,1 -73,3 3.13%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-30,0 -29,0 -3.29%	-72,3 -74,8 3.4%
Net income Million USD	Released Forecast Spread	-30,0 -29,0 -3.29%	-72,3 -74,8 3.4%
EPS USD	Released Forecast Spread	-1,40 -1,46 3.78%	-2,60 -2,68 3.13%
Announcement Date		15/02/18	05/03/19

2024-07-23	VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24	BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am	ARGENX SE: Q2 2024 Earnings Release
2024-07-29	RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29	NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29	CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30	CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30	SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30	XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30	SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)

2024-05-17 07:00 am	AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am	BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am	ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 08:05 am	THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am	CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14	TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-15 04:01 pm	CELCUITY INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm	ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm	ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 am	IMMUNOME, INC.: Q1 2024 Earnings Release